Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-α on Fanconi anemia hematopoietic stem and progenitor cells
Open Access
- 21 May 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (21) , 5111-5120
Abstract
Ectopic delivery of HOXB4 elicits the expansion of engrafting hematopoietic stem cells (HSCs). We hypothesized that inhibition of tumor necrosis factor-α (TNF-α) signaling may be central to the self-renewal signature of HOXB4. Because HSCs derived from Fanconi anemia (FA) knockout mice are hypersensitive to TNF-α, we studied Fancc−/− HSCs to determine the physiologic effects of HOXB4 on TNF-α sensitivity and the relationship of these effects to the engraftment defect of FA HSCs. Overexpression of HOXB4 reversed the in vitro hypersensitivity to TNF-α of Fancc−/− HSCs and progenitors (P) and partially rescued the engraftment defect of these cells. Coexpression of HOXB4 and the correcting FA-C protein resulted in full correction compared with wild-type (WT) HSCs. Ectopic expression of HOXB4 resulted in a reduction in both apoptosis and reactive oxygen species in Fancc−/− but not WT HSC/P. HOXB4 overexpression was also associated with a significant reduction in surface expression of TNF-α receptors on Fancc−/− HSC/P. Finally, enhanced engraftment was seen even when HOXB4 was expressed in a time-limited fashion during in vivo reconstitution. Thus, the HOXB4 engraftment signature may be related to its effects on TNF-α signaling, and this pathway may be a molecular target for timed pharmacologic manipulation of HSC during reconstitution.Keywords
This publication has 52 references indexed in Scilit:
- Distinct roles of stress-activated protein kinases in Fanconi anemia type C–deficient hematopoiesisBlood, 2009
- Rapid Lentiviral Transduction Preserves the Engraftment Potential of Fanca−/− Hematopoietic Stem CellsMolecular Therapy, 2008
- High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vectorJournal of Clinical Investigation, 2008
- TNFα blockade in human diseases: An overview of efficacy and safetyClinical Immunology, 2008
- TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cellsJournal of Clinical Investigation, 2007
- HOXB4's road map to stem cell expansionProceedings of the National Academy of Sciences, 2007
- Differential Effects of HOXB4 on Nonhuman Primate Short- and Long-Term Repopulating CellsPLOS Medicine, 2006
- A Rapid Method for Retrovirus-Mediated Identification of Complementation Groups in Fanconi Anemia PatientsMolecular Therapy, 2005
- A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group MNature Genetics, 2005
- Recombinant tumor necrosis factor: Species specificity for a variety of human and murine transformed cell linesCellular Immunology, 1986